ABPI LINC collates publicly available information on the open opportunities offered by ABPI member companies for research collaboration with the academic community. We hope this is a user-friendly resource for the UK academic community to help identify relevant opportunities for collaboration, and ultimately accelerate medical research for the benefit of patients.

The resource can be searched by research stage (preclinical/clinical), type of collaboration or resource (e.g. sharing compounds, resources, funding, investigator led studies), disease area (e.g. infectious disease), or company.

There are also a range of case studies available. These illustrate different types of ongoing collaboration and their benefits for all partners and patients.

We would welcome your comments and feedback on ABPI LINC. Please do get in touch through the Contact Us page.

About ABPI

The Association of the British Pharmaceutical Industry (ABPI) represents innovative research-based biopharmaceutical companies, large, medium and small, leading an exciting new era of biosciences in the UK.

Our industry, a major contributor to the economy of the UK, brings life-saving and life-enhancing medicines to patients. We represent companies who supply more than 80 per cent of all branded medicines used by the NHS and who are researching and developing the majority of the current medicines pipeline, ensuring that the UK remains at the forefront of helping patients prevent and overcome diseases.​

Globally our industry is researching and developing more than 7,000 new medicines.

For more information on the ABPI and our work, please visit our website: www.abpi.org.uk.